Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:album
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:The_Omicronians
|
| gptkbp:birth_date |
November 26, 2021
|
| gptkbp:characteristics |
immune evasion
potential for reinfection high transmissibility |
| gptkbp:clinical_trial |
ongoing for new treatments
ongoing for updated vaccines |
| gptkbp:community_impact |
increased mental health issues
changes in work patterns |
| gptkbp:data_usage |
higher than previous variants
|
| gptkbp:discovered_by |
gptkb:2021
|
| gptkbp:distribution |
global
|
| gptkbp:economic_impact |
increased inflation
disruptions in supply chains |
| gptkbp:feedback |
support for affected businesses
local initiatives for vaccination |
| gptkbp:genetic_diversity |
multiple spike protein mutations
|
| gptkbp:government_type |
emergency declarations made
funding for research increased |
| gptkbp:healthcare |
increased testing and vaccination efforts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Omicronian
|
| gptkbp:is_monitored_by |
ongoing genomic surveillance
|
| gptkbp:is_recognized_by |
gptkb:South_Africa
|
| gptkbp:is_vulnerable_to |
reduced against infection
|
| gptkbp:origin |
continuing to evolve
likely from mutations in a vaccinated individual new subvariants emerging |
| gptkbp:provides_information_on |
mask mandates reinstated
travel restrictions implemented |
| gptkbp:public_awareness |
increased media coverage
public health campaigns launched |
| gptkbp:research |
studies on long COVID effects
studies on transmissibility studies on vaccine response |
| gptkbp:research_focus |
treatment effectiveness
vaccine adaptation |
| gptkbp:scientific_classification |
Variant of Concern
|
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:subgenres |
BA.1
BA.2 BA.4 BA.5 |
| gptkbp:symptoms |
similar to other COVID-19 variants
|
| gptkbp:track |
tracked by health organizations
reported in multiple countries data shared globally |
| gptkbp:variant |
gptkb:SARS-Co_V-2
asymptomatic cases reported impact on children and adolescents increased risk of reinfection compared to Delta mild symptoms in most cases potential for increased hospitalization rates rapid spread in communities severe cases in vulnerable populations |